FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113088368> ?p ?o ?g. }

• W2113088368 abstract "Abstract Background Presumptive treatment for malaria is common in resource-limited settings, yet controversial given the imprecision of clinical diagnosis. The researchers compared costs of diagnosis and drugs for two strategies: (1) empirical treatment of malaria via clinical diagnosis; and (2) empirical diagnosis followed by treatment only with Giemsa smear confirmation. Methods Patients with a diagnosis of clinical malaria were recruited from a mission/university teaching hospital in southwestern Nigeria. The patients underwent free Giemsa thick (diagnosis) and thin (differentiation) smears, but paid for all anti-malarial drugs. Clinical diagnosis was made on clinicians' judgments based on symptoms, including fever, diarrhoea, headache, and body aches. The paediatric regimen was artesunate (6-9 tablets of 3 mg/kg on day one and 1.5 mg/kg for the next four days) plus amodiaquine (10 mg/kg day 1-2 and 5 mg/kg on day three in suspension). Adults were given two treatment options: option one (four and one-half 50 mg artesunate tablets on day one and nine tablets for the next four days, plus three 500 mg sulphadoxine/25 mg pyrimethamine tablets) and option two (same artesunate regimen plus nine 200 mg tablets of amodiaquine at 10 mg/kg day 1-2 and 5 mg/kg on day three). The researchers calculated the costs of smears/drugs from standard hospital charges. Results Doctors diagnosed 304 patients (170 adults ages >16 years and 134 pediatric) with clinical malaria, prescribing antimalarial drugs to all. Giemsa thick smears were positive in 115/304 (38%). The typical patient cost for a Giemsa smear was 550 Naira (US$3.74 in 2009). For children, the cost of testing all, but treating only Giemsa positives was N888 ($6.04)/child; the cost of empiric treatment of all who were clinically diagnosed was lower, N660 ($4.49)/child. For adults, the cost of testing all, but treating only Giemsa positives was N711 ($4.84)/adult for treatment option one (artesunate and sulphadoxine/pyrimethamine) and N730 ($4.97)/adult for option two (artesunate and amodiaquine). This contrasts to lower costs of empiric treatment for both options one (N610 = $4.14/adult) and two (N680=$4.63/adult). Conclusions Empiric treatment of all suspected cases of malaria was cheaper (at the end of the dry to the beginning of the rainy season) than only treating those who had microscopy-confirmed diagnoses of malaria, even though the majority of patients suspected to have malaria were negative via microscopy. One can acknowledge that giving many malaria-uninfected Nigerians anti-malarial drugs is undesirable for both their personal health and fears of drug resistance with overuse. Therefore, funding of rapid diagnostic tests whose performance exceeds the Giemsa smear is needed to achieve an ideal of diagnostic confirmation before treatment." @default.
• W2113088368 created "2016-06-24" @default.
• W2113088368 creator A5005976503 @default.
• W2113088368 creator A5013067240 @default.
• W2113088368 creator A5013095958 @default.
• W2113088368 creator A5042804572 @default.
• W2113088368 creator A5067064601 @default.
• W2113088368 creator A5075531430 @default.
• W2113088368 date "2010-12-01" @default.
• W2113088368 modified "2023-10-15" @default.
• W2113088368 title "Cost comparison of microscopy vs. empiric treatment for malaria in southwestern nigeria: a prospective study" @default.
• W2113088368 cites W1981255364 @default.
• W2113088368 cites W1984557452 @default.
• W2113088368 cites W1997729157 @default.
• W2113088368 cites W2053809309 @default.
• W2113088368 cites W2107542071 @default.
• W2113088368 cites W2123388015 @default.
• W2113088368 cites W2124263521 @default.
• W2113088368 cites W2160980734 @default.
• W2113088368 cites W2164181716 @default.
• W2113088368 doi "https://doi.org/10.1186/1475-2875-9-371" @default.
• W2113088368 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3152770" @default.
• W2113088368 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21176228" @default.
• W2113088368 hasPublicationYear "2010" @default.
• W2113088368 type Work @default.
• W2113088368 sameAs 2113088368 @default.
• W2113088368 citedByCount "11" @default.
• W2113088368 countsByYear W21130883682012 @default.
• W2113088368 countsByYear W21130883682013 @default.
• W2113088368 countsByYear W21130883682014 @default.
• W2113088368 countsByYear W21130883682015 @default.
• W2113088368 countsByYear W21130883682016 @default.
• W2113088368 countsByYear W21130883682020 @default.
• W2113088368 countsByYear W21130883682021 @default.
• W2113088368 crossrefType "journal-article" @default.
• W2113088368 hasAuthorship W2113088368A5005976503 @default.
• W2113088368 hasAuthorship W2113088368A5013067240 @default.
• W2113088368 hasAuthorship W2113088368A5013095958 @default.
• W2113088368 hasAuthorship W2113088368A5042804572 @default.
• W2113088368 hasAuthorship W2113088368A5067064601 @default.
• W2113088368 hasAuthorship W2113088368A5075531430 @default.
• W2113088368 hasBestOaLocation W21130883681 @default.
• W2113088368 hasConcept C126322002 @default.
• W2113088368 hasConcept C141071460 @default.
• W2113088368 hasConcept C142724271 @default.
• W2113088368 hasConcept C154488023 @default.
• W2113088368 hasConcept C187212893 @default.
• W2113088368 hasConcept C2776992834 @default.
• W2113088368 hasConcept C2777035104 @default.
• W2113088368 hasConcept C2777425658 @default.
• W2113088368 hasConcept C2778048844 @default.
• W2113088368 hasConcept C2778059366 @default.
• W2113088368 hasConcept C2778371730 @default.
• W2113088368 hasConcept C2781413609 @default.
• W2113088368 hasConcept C71924100 @default.
• W2113088368 hasConceptScore W2113088368C126322002 @default.
• W2113088368 hasConceptScore W2113088368C141071460 @default.
• W2113088368 hasConceptScore W2113088368C142724271 @default.
• W2113088368 hasConceptScore W2113088368C154488023 @default.
• W2113088368 hasConceptScore W2113088368C187212893 @default.
• W2113088368 hasConceptScore W2113088368C2776992834 @default.
• W2113088368 hasConceptScore W2113088368C2777035104 @default.
• W2113088368 hasConceptScore W2113088368C2777425658 @default.
• W2113088368 hasConceptScore W2113088368C2778048844 @default.
• W2113088368 hasConceptScore W2113088368C2778059366 @default.
• W2113088368 hasConceptScore W2113088368C2778371730 @default.
• W2113088368 hasConceptScore W2113088368C2781413609 @default.
• W2113088368 hasConceptScore W2113088368C71924100 @default.
• W2113088368 hasIssue "1" @default.
• W2113088368 hasLocation W21130883681 @default.
• W2113088368 hasLocation W21130883682 @default.
• W2113088368 hasLocation W21130883683 @default.
• W2113088368 hasLocation W21130883684 @default.
• W2113088368 hasOpenAccess W2113088368 @default.
• W2113088368 hasPrimaryLocation W21130883681 @default.
• W2113088368 hasRelatedWork W1576608948 @default.
• W2113088368 hasRelatedWork W2006887406 @default.
• W2113088368 hasRelatedWork W2106374162 @default.
• W2113088368 hasRelatedWork W2113088368 @default.
• W2113088368 hasRelatedWork W2144031245 @default.
• W2113088368 hasRelatedWork W2167847308 @default.
• W2113088368 hasRelatedWork W2402550396 @default.
• W2113088368 hasRelatedWork W2436584172 @default.
• W2113088368 hasRelatedWork W3092362443 @default.
• W2113088368 hasRelatedWork W2607052946 @default.
• W2113088368 hasVolume "9" @default.
• W2113088368 isParatext "false" @default.
• W2113088368 isRetracted "false" @default.
• W2113088368 magId "2113088368" @default.
• W2113088368 workType "article" @default.